Lesaka Technologies (LSAK, $4.37, $400M market cap) is a South African fintech beating analyst estimates by 100% for four consecutive quarters, guiding 36-57% EBITDA growth, trading at 12x forward P/E with only one analyst covering it, CEO bought $9M at $5, and the stock is down 12.8% over the past year. The operational turnaround is real. The market disconnect is extreme. But the merchant lending book is deteriorating fast, and nobody's talking about it.

What's Happening

Q2 FY2026 (Dec 31, 2025): Beat by 100% again. EPS $0.08 vs $0.04 estimate. Revenue $178.7M (+1.4% YoY). Operating margin 19%, up from 15% a year ago. CFO Dan Smith put a number on the endpoint: "trending toward 30% operating margin." CapEx as % of EBITDA simultaneously declining (46% → 33%). Platform economics inflecting.

Guidance acceleration: Q3 midpoint implies 27% revenue growth and 37% EBITDA growth — a material step-up from Q2's actual 16% revenue growth. Full-year EBITDA guidance reaffirmed at 36-57% growth. CEO Lincoln Mali: "excited about the earnings momentum we expect to take into FY 2027." This isn't sandbagging — it's a company guiding UP the curve after 14 consecutive quarters of beating.

Consumer lending inflection: ZAR 1.2B originations (+88% YoY), first quarter exceeding ZAR 1B. Outstanding book ZAR 1.5B (+106% YoY). The newer 9-month product is 40% of originations and growing. 78% repeat borrowers. 80% customers >2 years. CFO expects "strong earnings growth in Q3 and Q4" specifically from lending.

Competitive moat: Beat Capitec in net new grant beneficiary additions for Q2 — first time ever. 2M+ active consumers. 14.1% market share, up from 11.4%. Now piloting insurance sales beyond core grant base from Q3. Growing TAM, not just share.

Infrastructure buildout: Proprietary payment switch now processing 40% of merchant card volumes in-house. Bank Zero deposits will fund the lending book instead of debt (structural cash conversion improvement). Leverage at 2.5x, targeting 2x.

Insider signal: CEO Ali Mazanderani bought $9M at ≈$5 on Dec 31, 2025 (1.8M shares). Stock now at $4.37 — he's underwater and still buying. CFO Dan Smith bought $130K in December. This isn't symbolic. It's conviction.

Market response: Stock down 6.2% THIS WEEK despite the earnings beat. Down 12.8% over 1 year. RSI 32.4 (oversold). Forward P/E 12.1x on a company guiding 36-57% EBITDA growth. One analyst at $8 target (+83% upside). Short interest 0.2% — nobody's even paying attention.

The Problem Nobody's Addressing

Buried in Note 3 of the 10-Q (page 3579-3585): Merchant lending book credit quality is deteriorating fast.

Under-performing loans (payments in arrears) went from 4% to 11% in 6 months. That's a near tripling of early-stage delinquency. The non-performing category (payments ceased) held flat at 1%, but the pipeline feeding it just swelled.

Meanwhile: Consumer lending book (the growth engine) is 98%+ performing with 6.5% lifetime loss provision. But 40% of originations are from a new 9-month product with NO full-cycle default history. Management says they "expect modest non-material increase credit loss ratio" but provided zero data backing that claim.

The merchant lending book is ZAR 389M ($21.3M), pledged as security for the revolving credit facility. It's not the revenue driver (consumer lending is 4× larger). But it's collateral for the funding structure, and if it deteriorates further, the revolver gets tighter exactly when consumer lending is scaling fastest.

The Net1/UEPS Ghost

Lesaka was Net1 UEPS Technologies until May 2022. The name change wasn't cosmetic — it was an attempted exorcism.

The history: Net1's Cash Paymaster Services (CPS) subsidiary won the SASSA (South African Social Security Agency) contract to distribute social grants in 2012. The Constitutional Court ruled the contract invalid in 2014 for improper tender procedures. CPS was allowed to continue payments while SASSA failed to find a replacement. In 2018-2019, courts ordered CPS to repay R316M+ to SASSA for irregularly received implementation cost recovery. CPS sought business rescue (bankruptcy protection) in 2020 to avoid the repayment.

In 2020, Value Capital Partners invested R580M and began redefining strategy, appointing new board and management. The company changed its name to Lesaka in May 2022. Current CEO Lincoln Mali and executive chairman Ali Mazanderani are the new regime.

The pattern signal: This is the same corporate entity that operated in the same grant beneficiary space with a troubled governance track record. The 3.5-year accounting error disclosed in Q1 FY2026 (indirect taxes incorrectly claimed since June 2022, deemed "immaterial" but requiring restatement) isn't an isolated event — it's consistent with the legacy.

The new management talks about a "Lesaka Values Journey" involving every staff member to ensure "highest levels of customer service excellence, product innovation and ethical business practices." But the infrastructure was built by the old regime, and reputational baggage doesn't disappear with a ticker change.

The Decision Tree

If merchant credit deterioration is contained: The consumer lending inflection is real, the market is asleep, the CEO is buying $9M, and you're getting a 12x P/E on 36-57% EBITDA growth in an under-covered South African fintech. The thesis works.

If merchant credit deterioration accelerates: The collateral backing the revolver deteriorates, funding gets tighter, consumer lending growth stalls exactly when it needs capital, and the guidance gets walked back. The stock gaps down on a credit revision, not up on an earnings beat. You're catching a falling knife with governance baggage.

The critical data points:

1. Q3 merchant lending book performance (next quarter)
2. 9-month consumer product default rates (full-cycle data in 3-6 months)
3. Bank Zero deposit ramp (funding diversification away from revolver)

What the Market Sees

The disconnect: Stock going DOWN while fundamentals going UP. The question: Is the market ignoring this because it's illiquid and has baggage, or because it sees credit risk the bull case hasn't grappled with?

Escalation Recommendation

Don't size yet. This is a doorway state — could be a $8 story (Street is wrong, credit stabilizes, consumer lending compounds) or a $2 story (credit deteriorates, funding tightens, guidance gets cut). The pattern hasn't collapsed.

The research gaps:

1. Merchant credit trajectory: Need Q3 data. If under-performing stabilizes or reverses, the bear case weakens. If it hits 15-20%, the funding structure is at risk.
2. Consumer 9-month product performance: 40% of originations, zero full-cycle data. Management says "modest increase" in losses — need verification.
3. Net1 governance resolution: Has the new management structurally fixed the compliance/governance issues, or just rebranded? Talk to former employees, check subsequent filings for patterns.
4. Liquidity plan: $437K daily volume = uninvestable above small retail size. How do you exit if the thesis breaks?

If you already own it: Hold through Q3 earnings (guidance trajectory + merchant credit update). Exit if merchant under-performing exceeds 15% or consumer loss provision revised upward materially.

If you don't own it: Watch Q3 data. If merchant credit stabilizes + consumer losses stay <7% + guidance confirmed, THIS is the entry — oversold, under-covered, CEO buying, 12x P/E on accelerating growth. If credit deteriorates, you dodged the Net1 2.0 blowup.

The opportunity is real. The risk is also real. The next 90 days tell you which one wins.